Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

APREA THERAPEUTICS, INC.

(APRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on APREA THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) APREA THERAPEUTICS, INC.
Analyst Recommendations on APREA THERAPEUTICS, INC.
08/20APREA THERAPEUTICS : JPMorgan Downgrades Aprea Therapeutics to Underweight From Neutral
MT
08/16APREA THERAPEUTICS : HC Wainwright Adjusts Aprea Therapeutics' Price Target to $4 from $6, Keeps Neutral Rating
MT
08/16APREA THERAPEUTICS : Berenberg Bank Downgrades Aprea Therapeutics to Hold From Buy Following Clinical Hold on M..
MT
08/13APREA THERAPEUTICS : RBC Cuts Price Target on Aprea Therapeutics to $5 From $6 Amid FDA Hold on Lymphoid Malign..
MT
08/13APREA THERAPEUTICS : Morgan Stanley Lowers Aprea Therapeutics to Underweight From Equal-Weight, Price Target to..
MT
08/09APREA THERAPEUTICS : RBC Reduces Price Target on Aprea Therapeutics to $6 From $7, Maintains Sector Perform, Sp..
MT
05/07APREA THERAPEUTICS : RBC Cuts Price Target on Aprea Therapeutics to $7 From $8, Maintains Sector Perform, Specu..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 5
Last Close Price 4,75 $
Average target price 4,00 $
Spread / Average Target -15,8%
High Price Target 5,00 $
Spread / Highest target 5,26%
Low Price Target 3,00 $
Spread / Lowest Target -36,8%
Consensus detail
Consensus revision (last 18 months)